These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36703747)

  • 1. Truncated-semaphorin3A is a potential regulatory molecule to restore immune homeostasis in immune-mediated diseases.
    Eiza N; Kessler O; Sabag A; Neufeld G; Jones EY; Vadasz Z
    Front Pharmacol; 2022; 13():1085892. PubMed ID: 36703747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus.
    Eiza N; Sabag AD; Kessler O; Neufeld G; Vadasz Z
    J Autoimmun; 2023 Jan; 134():102960. PubMed ID: 36470209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis.
    Bejar J; Kessler O; Sabag AD; Sabo E; Itzhak OB; Neufeld G; Vadasz Z
    Front Immunol; 2018; 9():634. PubMed ID: 29670620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A regulatory role for CD72 expression on B cells in systemic lupus erythematosus.
    Vadasz Z; Haj T; Balbir A; Peri R; Rosner I; Slobodin G; Kessel A; Toubi E
    Semin Arthritis Rheum; 2014 Jun; 43(6):767-71. PubMed ID: 24461079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphorin 3A - a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus.
    Vadasz Z; Toubi E
    Lupus; 2012 Oct; 21(12):1266-70. PubMed ID: 22875653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Urine Secretion of Semaphorin3A in Lupus Patients with Proteinuria.
    Doron R; Merav L; Nasrin E; Adi SD; Elias T; Gleb S; Itzhak R; Michael R; Zahava V
    Inflammation; 2022 Apr; 45(2):603-609. PubMed ID: 34562225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The involvement of neuropilin-1 in primary immune thrombocytopenia].
    Zhou H; Yang JY; Xu PP; Liu L; Ding BJ; Liu JP; Li MJ; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):146-150. PubMed ID: 33858046
    [No Abstract]   [Full Text] [Related]  

  • 8. Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.
    Adi SD; Eiza N; Bejar J; Shefer H; Toledano S; Kessler O; Neufeld G; Toubi E; Vadasz Z
    Front Immunol; 2019; 10():550. PubMed ID: 30967873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin3A released from human dental pulp cells inhibits the increase in interleukin-6 and CXC chemokine ligand 10 production induced by tumor necrosis factor-α through suppression of nuclear factor-κB activation.
    Shindo S; Kumagai T; Shirawachi S; Takeda K; Shiba H
    Cell Biol Int; 2021 Jan; 45(1):238-244. PubMed ID: 32926524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.
    Vadasz Z; Haj T; Halasz K; Rosner I; Slobodin G; Attias D; Kessel A; Kessler O; Neufeld G; Toubi E
    Arthritis Res Ther; 2012 Jun; 14(3):R146. PubMed ID: 22697500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and Clinical Significance of Semaphorin 3A in serum and mononuclear cells in patients with systemic lupus erythematosus].
    Gao H; Ma XX; Guo Q; Zou YD; Zhong YC; Xie LF; Shao M; Zhang XW
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):370-374. PubMed ID: 28219195
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
    Barresi V; Tuccari G
    Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis.
    Takagawa S; Nakamura F; Kumagai K; Nagashima Y; Goshima Y; Saito T
    BMC Musculoskelet Disord; 2013 Jan; 14():40. PubMed ID: 23343469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 3A mitigates lipopolysaccharide-induced chondrocyte inflammation, apoptosis and extracellular matrix degradation by binding to Neuropilin-1.
    Zhang H; Lu Y; Wu B; Xia F
    Bioengineered; 2021 Dec; 12(2):9641-9654. PubMed ID: 34821196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
    Catalano A
    J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semaphorin 3A: Is a key player in the pathogenesis of asthma.
    Cozacov R; Halasz K; Haj T; Vadasz Z
    Clin Immunol; 2017 Nov; 184():70-72. PubMed ID: 28502680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Neuropilin-1 Ligand, Sema3A, Acts as a Tumor Suppressor in the Pathogenesis of Acute Leukemia.
    Yang ZG; Wen RT; Qi K; Li J; Zheng GX; Wang YF; Hong YG; Zhang YM
    Anat Rec (Hoboken); 2019 Jul; 302(7):1127-1135. PubMed ID: 30378769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin 3A inhibits allergic inflammation by regulating immune responses in a mouse model of allergic rhinitis.
    Xiang R; Xu Y; Zhang W; Kong YG; Tan L; Chen SM; Deng YQ; Tao ZZ
    Int Forum Allergy Rhinol; 2019 May; 9(5):528-537. PubMed ID: 30597767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of semaphorin-3A in autoimmune diseases.
    Liu LN; Li XM; Ye DQ; Pan HF
    Inflammopharmacology; 2018 Jun; 26(3):655-665. PubMed ID: 29696565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.
    Bouvrée K; Brunet I; Del Toro R; Gordon E; Prahst C; Cristofaro B; Mathivet T; Xu Y; Soueid J; Fortuna V; Miura N; Aigrot MS; Maden CH; Ruhrberg C; Thomas JL; Eichmann A
    Circ Res; 2012 Aug; 111(4):437-45. PubMed ID: 22723296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.